SAN DIEGO, Dec. 16, 2025 (GLOBE NEWSWIRE) — LPL Financial Holdings Inc. (Nasdaq: LPLA) (the “Company”) today released its monthly activity report for November 2025. Total advisory and brokerage assets at the end of November were $2.36 trillion, an increase of $12.5 billion, or 0.5%, compared to the end of October 2025. Total organic net new assets for November were $6.7 billion, translating to a 3.4% annualized growth rate. This included $0.1 billion of assets from First Horizon Bank that onboarded in November, and $0.3 billion of assets that off-boarded as part of the previously disclosed planned separation from misaligned large OSJs. Prior to these impacts, organic net new assets were $6.8 billion, translating to a 3.5% annualized growth rate. Total client cash balances at the end of November were $54.6 billion, a decrease of...

Nanterre, 16 December 2025 VINCI Autoroutes and VINCI Airports traffic in November 2025 I-      Change in VINCI Autoroutes’ intercity networks traffic  November YTD at the end of November (11 months)  % change 2025/2024 % change 2025/2024VINCI Autoroutes −3.4% +1.1%Light vehicles −3.7% +1.2%Heavy vehicles −1.6% +0.5%In November, the decline in traffic at VINCI Autoroutes was due to a different positioning of public holidays compared with last year*. Despite this unfavourable calendar effect, traffic has risen by 1.1% since the start of the year, with light vehicles up 1.2% and heavy vehicles up 0.5%. * November 1 (a Saturday this year, a Friday last year) and November 11 (a Tuesday this year, a Monday last year). II-      Change in VINCI Airports passenger traffic1  November YTD at the end of November(11 months)  %...

Retail momentum, disciplined execution, and strengthened liquidity position Company for growth Key HighlightsSales totaled $12.6 million in the quarter compared to $14.0 million in the prior-year quarter Retail and comparable store sales growth of 2.9%, resulting in a 21% two-year stack, reflecting continued retail momentum SG&A expenses decreased 26.5% in the quarter to $6.4 million, driven by a materially lower operating cost base Net loss narrowed to $0.6 million, from $1.6 million in the prior-year quarter $2.7 million revenue-linked financing completed during the quarter and $3.0 million private placement closed post quarter-end New store opened at Laurier Québec Mall in December with goal of adding 6 new locations in fiscal 2026MONTREAL, Dec. 16, 2025 (GLOBE NEWSWIRE) — DAVIDsTEA Inc. (TSX-Venture: DTEA) (“DAVIDsTEA”...

Improved profitability driven by consecutive quarters of gross margin expansion and SG&A leverage Inventories down 17% vs. last year with net liquidity of $88.6 million Affirming the higher end of previously issued fiscal 2025 Adjusted EBITDA guidance range MOUNT HOREB, Wisc., Dec. 16, 2025 (GLOBE NEWSWIRE) — Duluth Holdings Inc. (dba, Duluth Trading Company) (“Duluth Trading” or the “Company”) (NASDAQ: DLTH), a lifestyle brand of men’s and women’s workwear, casual wear, outdoor apparel and accessories, today announced its financial results for the fiscal Third Quarter ended November 2, 2025. Summary of the Third Quarter ended November 2, 2025 Net loss reduced to $10.1 million compared to net loss of $28.2 million in the prior year Third Quarter.   Reported EPS loss of $0.29; and adjusted EPS1 loss of $0.23 adjusted for...

VEON Announces Release Date for Full Year and Fourth Quarter 2025 Results of Both VEON and Kyivstar Dubai, December 16, 2025 – VEON Ltd. (Nasdaq: VEON), a global digital operator (“VEON” or “the Company”), today confirms that VEON and its operating company Kyivstar Group Limited (“Kyivstar”, Nasdaq: KYIV), will release its selected consolidated financial and operating results for the fourth quarter and full year ended December 31, 2025, on Monday, March 16, 2026. This date has been set in respect of the Eid holidays expected to occur later that week in Dubai. The results will be released at 8:00 GST (5:00 CET, 0:00 EST) on that day. VEON will also host a results conference call with senior management on the same day, Monday, March 16, 2026, while Kyivstar will hold its call the following day, Tuesday, March 17, 2026. Details regarding...

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, JAPAN OR SOUTH AFRICA OR IN ANY OTHER JURISDICTION IN WHICH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL OR REQUIRE REGISTRATION. This announcement is not a prospectus and does not constitute an offer to sell or the solicitation of an offer to purchase the securities described herein, nor shall there be any sale of the securities referred to herein in or into any jurisdiction where such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. Neither this communication nor anything contained herein shall form the basis of, or be relied upon in connection with, any offer or commitment whatsoever in any jurisdiction....

Continued profitability expansion with net income of $0.7 million versus net loss of $(1.1) million in Q2 FY2025, and up from net income of $0.4 million in Q1 FY2026 Revenue of $11.2 million; USU increases 9% year-over-year Disciplined cost controls deliver operating income of $1.0 million Positive Adjusted EBITDA of $2.5 million versus $1.5 million; Adjusted EBITDA margin of 22% versus 14% Fourth consecutive quarter of positive operating cash flow of $0.5 millionPHOENIX, Dec. 15, 2025 (GLOBE NEWSWIRE) — Aspen Group, Inc. (OTCQB: ASPU) (“AGI” or the “Company”), an education technology holding company, today announced financial results for its second quarter of fiscal year 2026 ended October 31, 2025. Second Quarter Fiscal Year 2026 Summary Results  Three Months Ended October 31,   Six Months Ended October 31,$ in millions,...

Abivax Presents Third Quarter 2025 Financial ResultsCash and cash equivalents of EUR 589.7 (as of September 30, 2025) with a cash runway into Q4 2027PARIS, France, December 15, 2025, 10:05 p.m. CET – Abivax SA (Euronext Paris: FR0012333284 – ABVX / Nasdaq – ABVX) (“Abivax” or the “Company”), a clinical-stage biotechnology company focused on developing therapeutics that harness the body’s natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases, announced today its key financial information for the nine months ended September 30, 2025. The unaudited interim condensed consolidated financial statements as of and for the three and nine months ending September 30, 2025, reviewed by the Company’s Board of Directors on December 11, 2025, have been reviewed by the Company’s external auditors. Abivax...

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, JAPAN OR SOUTH AFRICA OR IN ANY OTHER JURISDICTION IN WHICH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL OR REQUIRE REGISTRATION. This announcement is not a prospectus and does not constitute an offer to sell or the solicitation of an offer to purchase the securities described herein, nor shall there be any sale of the securities referred to herein in or into any jurisdiction where such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. Neither this communication nor anything contained herein shall form the basis of, or be relied upon in connection with, any offer or commitment whatsoever in any jurisdiction....

NEW YORK, Dec. 15, 2025 (GLOBE NEWSWIRE) — Value Line, Inc., (NASDAQ: VALU) reported financial results for the first half of its fiscal year, ended October 31, 2025.During the six months ended October 31, 2025, the Company’s net income of $12,142,000, or $1.29 per share, was 4.9% above net income of $11,572,000, or $1.23 per share, for the six months ended October 31, 2024.   The Company’s revenues of $10,275,000 from Eulav Asset Management (EAM) increased $1,404,000 or 15.8% above the prior fiscal year.   During the six months ended October 31, 2025, the Company’s total investment gains of $3,201,000 was 10.6% above total investment gains in the prior fiscal year.   Retained earnings at October 31, 2025, were $119,426,000, an increase of 5.3% compared to retained earnings at April 30, 2025.   Shareholders’ equity reached $105,489,000...